Who owns ANBIO BIOTECHNOLOGY?
- Ticker: NNNN
- CUSIP Number: g0367b105
Tip: Access positions for across all investors
Analyze quarterly positions in Anbio Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Anbio Biotechnology stock
Who bought or sold ANBIO BIOTECHNOLOGY this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 26k | $960k | 50% | Sep 2025 |
|
| Marshall Wace | 10k | $389k | 100% | Sep 2025 |
|
| Millennium Management | 7.1k | $264k | 100% | Sep 2025 |
|
| XTX Topco | 6.9k | $257k | 100% | Sep 2025 |
|
| Hrt Financial | 6.0k | $223k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 2.4k | $90k | 92% | Sep 2025 |
|
| UBS Group | 960.00 | $36k | -91% | Sep 2025 |
|
| Morgan Stanley | 400.00 | $13k | 100% | Jun 2025 |
|
| Wells Fargo & Company | 100.00 | $3.7k | 0% | Sep 2025 |
|